Increased susceptibility of Sf1+/- mice to azoxymethane-induced colon tumorigenesis

Cancer Science

Volumn 98, Issue 12, 2007, Pages 1862-1867

  Shitashige, Miki ^a   Satow, Reiko ^a   Honda, Kazufumi ^a   Ono, Masaya ^a   Hirohashi, Setsuo ^a   Yamada, Tesshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; SPLICING FACTOR 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; FEMALE; GENE TARGETING; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR VOLUME;

ANIMALS; AZOXYMETHANE; BETA CATENIN; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA-BINDING PROTEINS; GENES, LETHAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMEODOMAIN PROTEINS; INTRONS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 35548990932     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00629.x     Document Type: Article

References (34)

1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-70.
2. Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM. Casein kinase I phosphorylates and destabilizes the β-catenin degradation complex. Proc Natl Acad Sci USA 2002; 99: 1182-7.
3. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 2003; 94: 225-9.
4. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-Catenin is a target for the ubiquitin-proteasome pathway. Embo J 1997; 16: 3797-804.
5. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000; 287: 1606-9.
6. Miller JR, Moon RT. Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev 1996; 10: 2527-39.
7. -/-colon carcinoma. Science 1997; 275: 1784-7.
8. Morin PJ, Sparks AB, Korinek V et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275: 1787-90.
9. He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
10. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
11. van de Wetering M, Sancho E, Verweij C et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111: 241-50.
12. Yamada T, Takaoka AS, Naishiro Y et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis. Cancer Res 2000; 60: 4761-6.
13. Shitashige M, Naishiro Y, Idogawa M et al. Involvement of splicing factor-1 in β-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Gastroenterology 2007; 132: 1039-54.
14. Araki K, Imaizumi T, Sekimoto T et al. Exchangeable gene trap using the Cre/mutated lox system. Cell Mol Biol 1999; 45: 737-50.
15. Taniwaki T, Haruna K, Nakamura H et al. Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-β geo cassette. Dev Growth Differ 2005; 47: 163-72.
16. Yagi T, Tokunaga T, Furuta Y et al. A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem 1993; 214: 70-6.
17. Fraser LR, Drury LM. The relationship between sperm concentration and fertilization in vitro of mouse eggs. Biol Reprod 1975; 13: 513-8.
18. Nozaki T, Fujihara H, Watanabe M et al. Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane. Cancer Sci 2003; 94: 497-500.
19. Min/+ mice. Cancer Res 2003; 63: 895-901.
20. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 1993; 53: 2566-70.
21. Seike M, Kondo T, Mori Y et al. Proteomic analysis of intestinal epithelial cells expressing stabilized β-catenin. Cancer Res 2003; 63: 4641-7.
22. Papanikolaou A, Wang QS, Delker DA, Rosenberg DW. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett 1998; 130: 29-34.
23. Idogawa M, Masutani M, Shitashige M et al. Ku70 and poly (ADP-ribose) polymerase-1 competitively regulate β-catenin and T-cell factor-4-mediated gene transactivation: Possible linkage of DNA damage recognition and Wnt signaling. Cancer Res 2007; 67: 911-8.
24. Korinek V, Barker N, Moerer P et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998; 19: 379-83.
25. Takahashi M, Nakatsugi S, Sugimura T, Wakabayashi K. Frequent mutations of the β-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 2000; 21: 1117-20.
26. De Filippo C, Caderni G, Bazzicalupo M et al. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br J Cancer 1998; 77: 2148-51.
27. Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 2006; 27: 162-9.
28. Goldstrohm AC, Albrecht TR, Sune C, Bedford MT, Garcia-Blanco MA. The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol 2001; 21: 7617-28.
29. Liu Z, Luyten I, Bottomley MJ et al. Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science 2001; 294: 1098-102.
30. Sato S, Idogawa M, Honda K et al. β-Catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology 2005; 129: 1225-36.
31. Tanaka S, Sugimachi K, Kameyama T et al. Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology 2003; 37: 1122-9.
32. Jang JH, Shin KH, Park YJ, Lee RJ, McKeehan WL, Park JG. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. Cancer Res 2000; 60: 4049-52.
33. Xu X, Yang D, Ding JH et al. ASF/SF2-regulated CaMKIIδ alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 2005; 120: 59-72.
34. Isono K, Mizutani-Koseki Y, Komori T, Schmidt-Zachmann MS, Koseki H. Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1. Genes Dev 2005; 19: 536-41.